BIOMAT Database Logo BIOMAT Database Logo

The efficacy of DFO-HOPO, DTPA-DX and DTPA for enhancing the excretion of plutonium and ameriicum from the rat. 1991

G N Stradling, and S A Gray, and J C Moody, and A Hodgson, and K N Raymond, and P W Durbin, and S J Rodgers, and D L White, and P N Turowski
National Radiological Protection Board, Didcot, Oxon, UK.

A hydroxypridinone derivative of desferrioxamine (Na-DFO-HOPO), a dihydroxamic derivative of diethylenetriaminepenta-acetic acid (ZnNa-DTPA-DX), and DTPA (CaNa3- and ZnNa3-DTPA) were tested at dosages of 30 mumol kg-1 for their ability to remove 238Pu or 241Am from rats after their intravenous injection as citrate or inhalation as nitrate. The most effective treatment regimen for injected Pu was the repeated administration of DFO-HOPO; by 7 days the body content was reduced to 8% of that in untreated animals. Repeated dosages of 3 mumol kg-1 DFO-HOPO were as effective as those of 30 mumol kg-1 DTPA. After inhalation of Pu nitrate, repeated treatment with DTPA, DTPA-DX or DFO-HOPO reduced the body content by 7 days to, respectively, 10, 15 and 31% of those in untreated animals. After inhalation of Am, DTPA-DX and DTPA were equally effective, the body contents being reduced to 7% of control values with repeated treatment. Injection of DFO-HOPO was ineffective for enhancing the elimination of inhaled or injected Am. The results confirm the strategy of examining the use of siderophore analogues for the decorporation of Pu or Am. However, at present DTPA should remain the agent of choice, particularly after inhalation.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D011005 Plutonium A naturally radioactive element of the actinide metals series. It has the atomic symbol Pu, and atomic number 94. Plutonium is used as a nuclear fuel, to produce radioisotopes for research, in radionuclide batteries for pacemakers, and as the agent of fission in nuclear weapons.
D011728 Pyridones Pyridine derivatives with one or more keto groups on the ring. Pyridinones
D002614 Chelating Agents Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. Chelating Agent,Chelator,Complexons,Metal Antagonists,Chelators,Metal Chelating Agents,Agent, Chelating,Agents, Chelating,Agents, Metal Chelating,Antagonists, Metal,Chelating Agents, Metal
D003666 Decontamination The removal of contaminating material, such as radioactive materials, biological materials, or CHEMICAL WARFARE AGENTS, from a person or object.
D003676 Deferoxamine Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form. Desferrioxamine,Deferoxamine B,Deferoxamine Mesilate,Deferoxamine Mesylate,Deferoxamine Methanesulfonate,Deferoximine,Deferrioxamine B,Desferal,Desferioximine,Desferrioxamine B,Desferrioxamine B Mesylate,Desferroxamine,Mesilate, Deferoxamine,Mesylate, Deferoxamine,Mesylate, Desferrioxamine B,Methanesulfonate, Deferoxamine
D004369 Pentetic Acid An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium. DTPA,Diethylenetriamine Pentaacetic Acid,Pentetates,Penthanil,Ca-DTPA,CaDTPA,CaNa-DTPA,Calcium Trisodium Pentetate,DETAPAC,Indium-DTPA,Mn-Dtpa,Pentacin,Pentacine,Pentaind,Pentetate Calcium Trisodium,Pentetate Zinc Trisodium,Sn-DTPA,Zinc-DTPA,Indium DTPA,Pentaacetic Acid, Diethylenetriamine,Pentetate, Calcium Trisodium,Zinc DTPA
D005260 Female Females
D006877 Hydroxamic Acids A class of weak acids with the general formula R-CONHOH. Hydroxamic Acid,Acid, Hydroxamic,Acids, Hydroxamic
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol

Related Publications

G N Stradling, and S A Gray, and J C Moody, and A Hodgson, and K N Raymond, and P W Durbin, and S J Rodgers, and D L White, and P N Turowski
Early chelation therapy for injected Pu-238 and Am-241 in the rat: comparison of 3,4,3-LIHOPO, DFO-HOPO, DTPA-DX, DTPA and DFOA.
June 1993, International journal of radiation biology,
G N Stradling, and S A Gray, and J C Moody, and A Hodgson, and K N Raymond, and P W Durbin, and S J Rodgers, and D L White, and P N Turowski
Action of DTPA on hepatic plutonium I. Quantitation of the DTPA-induced biliary excretion of plutonium in the rat.
April 1978, Radiation research,
G N Stradling, and S A Gray, and J C Moody, and A Hodgson, and K N Raymond, and P W Durbin, and S J Rodgers, and D L White, and P N Turowski
Octadentate hydroxypyridinonate (HOPO) ligands for plutonium (i.v.): pharmacokinetics and oral efficacy.
January 2003, Radiation protection dosimetry,
G N Stradling, and S A Gray, and J C Moody, and A Hodgson, and K N Raymond, and P W Durbin, and S J Rodgers, and D L White, and P N Turowski
Action of DTPA on hepatic plutonium. III. Evidence for a direct chelation mechanism for DTPA-induced excretion of monomeric plutonium into rat bile.
October 1979, Radiation research,
G N Stradling, and S A Gray, and J C Moody, and A Hodgson, and K N Raymond, and P W Durbin, and S J Rodgers, and D L White, and P N Turowski
Efficacy of Zn-DTPA and Ca-DTPA in removing plutonium from the human body.
November 1978, Health physics,
G N Stradling, and S A Gray, and J C Moody, and A Hodgson, and K N Raymond, and P W Durbin, and S J Rodgers, and D L White, and P N Turowski
Efficacy of 3,4,3-LIHOPO for enhancing the excretion of plutonium from rat after simulated wound contamination as a tributyl-n-phosphate complex.
December 1995, International journal of radiation biology,
G N Stradling, and S A Gray, and J C Moody, and A Hodgson, and K N Raymond, and P W Durbin, and S J Rodgers, and D L White, and P N Turowski
Efficacy of Zn-DTPA in removing plutonium from the human body.
February 1976, Health physics,
G N Stradling, and S A Gray, and J C Moody, and A Hodgson, and K N Raymond, and P W Durbin, and S J Rodgers, and D L White, and P N Turowski
Evaluation of DFO-HOPO as an octadentate chelator for zirconium-89.
July 2017, Chemical communications (Cambridge, England),
G N Stradling, and S A Gray, and J C Moody, and A Hodgson, and K N Raymond, and P W Durbin, and S J Rodgers, and D L White, and P N Turowski
Specific Sequestering Agents for the Actinides. 29. Stability of the Thorium(IV) Complexes of Desferrioxamine B (DFO) and Three Octadentate Catecholate or Hydroxypyridinonate DFO Derivatives: DFOMTA, DFOCAMC, and DFO-1,2-HOPO. Comparative Stability of the Plutonium(IV) DFOMTA Complex(1).
July 1996, Inorganic chemistry,
G N Stradling, and S A Gray, and J C Moody, and A Hodgson, and K N Raymond, and P W Durbin, and S J Rodgers, and D L White, and P N Turowski
Interpretation of human urinary excretion of plutonium for cases treated with DTPA.
June 1972, Health physics,
Copied contents to your clipboard!